| Record Information |
|---|
| Version | 1.0 |
|---|
| Creation date | 2010-04-08 22:04:37 UTC |
|---|
| Update date | 2020-09-17 15:41:38 UTC |
|---|
| Primary ID | FDB000574 |
|---|
| Secondary Accession Numbers | Not Available |
|---|
| Chemical Information |
|---|
| FooDB Name | Pyridoxine |
|---|
| Description | Pyridoxine, also known as pyridoxol or vitamin B6, belongs to the class of organic compounds known as pyridoxines. These are pyridoxal derivatives in which the carbaldehyde group at position 2 of the pyridoxal moiety is replaced by a hydroxymethyl group. Pyridoxine is a very strong basic compound (based on its pKa). Pyridoxine exists in all living species, ranging from bacteria to humans. Within humans, pyridoxine participates in a number of enzymatic reactions. In particular, pyridoxine can be converted into pyridoxal; which is catalyzed by the enzyme pyridoxine-5'-phosphate oxidase. In addition, pyridoxine can be converted into pyridoxine 5'-phosphate through its interaction with the enzyme pyridoxal kinase. In humans, pyridoxine is involved in vitamin B6 metabolism. Outside of the human body, Pyridoxine is found, on average, in the highest concentration within a few different foods, such as common sages, tarragons, and summer savories and in a lower concentration in hushpuppies, alaska pollocks, and clupeinae (herring, sardine, sprat). Pyridoxine has also been detected, but not quantified in, several different foods, such as ucuhuba, pikeperchs, whiskies, fruit gums, and ginsengs. This could make pyridoxine a potential biomarker for the consumption of these foods. Pyridoxine is a potentially toxic compound. |
|---|
| CAS Number | 65-23-6 |
|---|
| Structure | |
|---|
| Synonyms | | Synonym | Source |
|---|
| 2-Methyl-3-hydroxy-4,5-dihydroxymethylpyridine | ChEBI | | 3-Hydroxy-4,5-bis(hydroxymethyl)-2-methylpyridine | ChEBI | | 3-Hydroxy-4,5-dimethylol-alpha-picoline | ChEBI | | 5-Hydroxy-6-methyl-3,4-pyridinedimethanol | ChEBI | | Pyridoxol | ChEBI | | Vitamin b6 | ChEBI | | 3-Hydroxy-4,5-dimethylol-a-picoline | Generator | | 3-Hydroxy-4,5-dimethylol-α-picoline | Generator | | 2-Methyl-3-hydroxy-4,5-bis(hydroxymethyl)pyridine | HMDB | | 2-Methyl-3-hydroxy-4,5-di(hydroxymethyl)pyridine | HMDB | | 2-Methyl-4,5-bis(hydroxymethyl)-3-hydroxypyridine | HMDB | | 3-Hydroxy-2-picoline-4,5-dimethanol | HMDB | | Adermine | HMDB | | Gravidox | HMDB | | Hydoxin | HMDB | | Piridossina | HMDB | | Piridoxina | HMDB | | Pyridoxin | HMDB | | Pyridoxinum | HMDB | | Pyridoxolum | HMDB | | Pyridoxol hydrochloride | HMDB | | Rodex | HMDB | | Pyridoxine hydrochloride | HMDB | | 2-methyl-3-hydroxy-4,5-dihydroxymethylpyridine | biospider | | 2-methyl-4,5-dimethylol-pyridin-3-ol | biospider | | 2-Picoline-4,5-dimethanol, 3-hydroxy- | biospider | | 3-hydroxy-2-Picoline-4,5-dimethanol | biospider | | 3,4-Pyridinedimethanol, 5-hydroxy-6-methyl- | biospider | | 4,5-Bis(hydroxymethyl)-2-methyl-3-pyridinol | biospider | | 4,5-bis(hydroxymethyl)-2-methylpyridine-3-ol | biospider | | 5-Hydroxy-6-methyl-3,4-pyridinedimethanol, 9CI | db_source | | Aderoxine | biospider | | Bezatin | biospider | | Hexabetalin | biospider | | Hexabion | biospider | | Pirivitol | biospider | | Pridoxine | biospider | | Vitamin B6 | manual | | Vitamin B6, 8CI | db_source |
|
|---|
| Predicted Properties | |
|---|
| Chemical Formula | C8H11NO3 |
|---|
| IUPAC name | 4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol |
|---|
| InChI Identifier | InChI=1S/C8H11NO3/c1-5-8(12)7(4-11)6(3-10)2-9-5/h2,10-12H,3-4H2,1H3 |
|---|
| InChI Key | LXNHXLLTXMVWPM-UHFFFAOYSA-N |
|---|
| Isomeric SMILES | CC1=C(O)C(CO)=C(CO)C=N1 |
|---|
| Average Molecular Weight | 169.1778 |
|---|
| Monoisotopic Molecular Weight | 169.073893223 |
|---|
| Classification |
|---|
| Description | Belongs to the class of organic compounds known as pyridoxines. These are pyridoxal derivatives in which the carbaldehyde group at position 2 of the pyridoxal moiety is replaced by a hydroxymethyl group. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Pyridines and derivatives |
|---|
| Sub Class | Pyridoxines |
|---|
| Direct Parent | Pyridoxines |
|---|
| Alternative Parents | |
|---|
| Substituents | - Pyridoxine
- Methylpyridine
- Hydroxypyridine
- Heteroaromatic compound
- Azacycle
- Organic nitrogen compound
- Organic oxygen compound
- Organopnictogen compound
- Hydrocarbon derivative
- Aromatic alcohol
- Primary alcohol
- Organooxygen compound
- Organonitrogen compound
- Alcohol
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
|
| Physiological effect | Health effect: |
|---|
| Disposition | Route of exposure: Source: Biological location: |
|---|
| Role | Industrial application: |
|---|
| Physico-Chemical Properties |
|---|
| Physico-Chemical Properties - Experimental | | Property | Value | Reference |
|---|
| Physical state | Solid | |
|---|
| Physical Description | Not Available | |
|---|
| Mass Composition | C 56.80%; H 6.55%; N 8.28%; O 28.37% | DFC |
|---|
| Melting Point | Mp 160° | DFC |
|---|
| Boiling Point | Not Available | |
|---|
| Experimental Water Solubility | Not Available | |
|---|
| Experimental logP | -0.77 | SANGSTER (1993) |
|---|
| Experimental pKa | pKa2 8.96 (25°, 0.15M NaCl) | DFC |
|---|
| Isoelectric point | Not Available | |
|---|
| Charge | 0 | |
|---|
| Optical Rotation | Not Available | |
|---|
| Spectroscopic UV Data | Not Available | |
|---|
| Density | Not Available | |
|---|
| Refractive Index | Not Available | |
|---|
|
|---|
| Spectra |
|---|
| Spectra | |
|---|
| EI-MS/GC-MS | | Type | Description | Splash Key | View |
|---|
| EI-MS | Mass Spectrum (Electron Ionization) | splash10-1003-6900000000-1237eaf82dfadfd54d4b | 2014-09-20 | View Spectrum | | GC-MS | Pyridoxine, 3 TMS, GC-MS Spectrum | splash10-000t-0940000000-30b4702623a6d8fcb4bb | Spectrum | | GC-MS | Pyridoxine, non-derivatized, GC-MS Spectrum | splash10-001j-0690000000-0581e2b42fa48c1ea498 | Spectrum | | GC-MS | Pyridoxine, 3 TMS, GC-MS Spectrum | splash10-00di-9330000000-32929ff06762b9f5887f | Spectrum | | GC-MS | Pyridoxine, 3 TMS, GC-MS Spectrum | splash10-001i-0490000000-34a09ddbbb462aeb02a6 | Spectrum | | GC-MS | Pyridoxine, non-derivatized, GC-MS Spectrum | splash10-0f6x-9400000000-486db54a30b61c2eb9d4 | Spectrum | | GC-MS | Pyridoxine, non-derivatized, GC-MS Spectrum | splash10-000t-0940000000-30b4702623a6d8fcb4bb | Spectrum | | GC-MS | Pyridoxine, non-derivatized, GC-MS Spectrum | splash10-001j-0690000000-0581e2b42fa48c1ea498 | Spectrum | | GC-MS | Pyridoxine, non-derivatized, GC-MS Spectrum | splash10-00di-9330000000-32929ff06762b9f5887f | Spectrum | | GC-MS | Pyridoxine, non-derivatized, GC-MS Spectrum | splash10-001i-0490000000-34a09ddbbb462aeb02a6 | Spectrum | | GC-MS | Pyridoxine, non-derivatized, GC-MS Spectrum | splash10-001j-0790000000-6f8f6e679e03f9119a65 | Spectrum | | Predicted GC-MS | Pyridoxine, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | splash10-0f79-0900000000-0f727b3e23c2481951e8 | Spectrum | | Predicted GC-MS | Pyridoxine, 3 TMS, Predicted GC-MS Spectrum - 70eV, Positive | splash10-00di-7079000000-2f143e187cb8c078f936 | Spectrum | | Predicted GC-MS | Pyridoxine, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Pyridoxine, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Pyridoxine, TMS_1_1, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Pyridoxine, TMS_1_2, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Pyridoxine, TMS_1_3, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Pyridoxine, TMS_2_1, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Pyridoxine, TMS_2_2, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Pyridoxine, TMS_2_3, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Pyridoxine, TBDMS_1_1, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Pyridoxine, TBDMS_1_2, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Pyridoxine, TBDMS_1_3, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Pyridoxine, TBDMS_2_1, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Pyridoxine, TBDMS_2_2, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum |
|
|---|
| MS/MS | | Type | Description | Splash Key | View |
|---|
| MS/MS | LC-MS/MS Spectrum - Quattro_QQQ 10V, Positive (Annotated) | splash10-0vi0-0900000000-bd0de86c072765a5caad | 2012-07-24 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Quattro_QQQ 25V, Positive (Annotated) | splash10-001i-3900000000-2018b406a3c75213b733 | 2012-07-24 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Quattro_QQQ 40V, Positive (Annotated) | splash10-0059-9200000000-e69bb531deb2a103a476 | 2012-07-24 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - EI-B (HITACHI M-80) , Positive | splash10-0f6x-9400000000-77c43a946c4ae1abf3b9 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 10V, Negative | splash10-014i-0900000000-479d4492cc8d634fa366 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 20V, Negative | splash10-0udi-0900000000-486d6a4e5e1a731b7c54 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 30V, Negative | splash10-05fr-0900000000-4ef09ce9c04561a1085e | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 40V, Negative | splash10-0ab9-1900000000-3298adf6db36689d5d43 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 50V, Negative | splash10-0a6r-7900000000-6711954ee96f08344434 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 10V, Positive | splash10-00di-0900000000-234e90d43a7febd7a098 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 20V, Positive | splash10-0udi-0900000000-137080765c0035b45258 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 30V, Positive | splash10-001i-0900000000-882ee900a8bba08e2c7c | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 40V, Positive | splash10-003r-8900000000-e0e11797b63cea991d81 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 50V, Positive | splash10-0059-9100000000-c25384179219411af02c | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) , Positive | splash10-0ue9-0900000000-c0e149ce890192397b7f | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) , Negative | splash10-0v4i-0900000000-f9f378af3d47ab006806 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ , negative | splash10-014i-0900000000-479d4492cc8d634fa366 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ , negative | splash10-0udi-0900000000-486d6a4e5e1a731b7c54 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ , negative | splash10-05fr-0900000000-4ef09ce9c04561a1085e | 2017-09-14 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-0uk9-0900000000-eab5b3411261744df750 | 2015-05-26 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-0ue9-0900000000-cc4dc8719602182ef1eb | 2015-05-26 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-001i-5900000000-1c2637733578fcdd7c6a | 2015-05-26 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-014i-0900000000-e89cc69d8b21012ff982 | 2015-05-27 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-059i-0900000000-0ad8d09e042015cb2e33 | 2015-05-27 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-0a4i-9500000000-577a3d87899ca47d539f | 2015-05-27 | View Spectrum |
|
|---|
| NMR | | Type | Description | | View |
|---|
| 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, experimental) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, D2O, experimental) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, D2O, experimental) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | | Spectrum | | 2D NMR | [1H, 1H]-TOCSY. Unexported temporarily by An Chi on Oct 15, 2021 until json or nmrML file is generated. 2D NMR Spectrum (experimental) | | Spectrum | | 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | | Spectrum |
|
|---|
| External Links |
|---|
| ChemSpider ID | 1025 |
|---|
| ChEMBL ID | CHEMBL1364 |
|---|
| KEGG Compound ID | C00314 |
|---|
| Pubchem Compound ID | 1054 |
|---|
| Pubchem Substance ID | Not Available |
|---|
| ChEBI ID | 16709 |
|---|
| Phenol-Explorer ID | Not Available |
|---|
| DrugBank ID | DB00165 |
|---|
| HMDB ID | HMDB00239 |
|---|
| CRC / DFC (Dictionary of Food Compounds) ID | BDV40-Q:BDV40-Q |
|---|
| EAFUS ID | 3262 |
|---|
| Dr. Duke ID | VITAMIN-B-6|VIT-B-6|PYRIDOXINE |
|---|
| BIGG ID | 34590 |
|---|
| KNApSAcK ID | Not Available |
|---|
| HET ID | Not Available |
|---|
| Food Biomarker Ontology | Not Available |
|---|
| VMH ID | Not Available |
|---|
| Flavornet ID | Not Available |
|---|
| GoodScent ID | Not Available |
|---|
| SuperScent ID | Not Available |
|---|
| Wikipedia ID | Pyridoxine |
|---|
| Phenol-Explorer Metabolite ID | Not Available |
|---|
| Duplicate IDS | Not Available |
|---|
| Old DFC IDS | Not Available |
|---|
| Associated Foods |
|---|
| Food | Content Range | Average | Reference |
|---|
| Food | | | Reference |
|---|
|
| Biological Effects and Interactions |
|---|
| Health Effects / Bioactivities | | Descriptor | ID | Definition | Reference |
|---|
| Analgesic | 35480 | An agent that relieves pain by reducing or blocking pain signals in the brain, commonly used to manage acute or chronic pain, inflammation, and fever, with therapeutic applications in surgery, injury, and disease treatment. | DUKE | | Anti-acne | 50177 | An agent that reduces acne symptoms, commonly used in managing acne vulgaris by minimizing oil production, preventing clogged pores, and decreasing bacterial growth, thereby reducing inflammation and promoting healthy skin. | DUKE | | Anti-aggregant | | An agent that prevents platelet aggregation, reducing blood clot formation. Its biological role is to inhibit platelet activation, and its therapeutic applications include preventing thrombosis and stroke. Key medical uses include treating cardiovascular diseases, such as myocardial infarction and atrial fibrillation, and managing conditions that increase the risk of blood clots. | DUKE | | Anti-anemic | 52217 | An agent that treats or prevents anemia by increasing red blood cell production or enhancing iron utilization, commonly used to manage iron-deficiency anemia, vitamin deficiency anemia, and other blood disorders, promoting healthy oxygen delivery to tissues and organs. | DUKE | | Anti-asthmatic | 49167 | An agent that relieves bronchospasm and inflammation, commonly used to manage asthma symptoms, chronic obstructive pulmonary disease (COPD), and other respiratory disorders, improving lung function and overall respiratory health. | DUKE | | Anti-atherosclerotic | 38070 | An agent that prevents or slows the formation of atherosclerosis, a condition characterized by plaque buildup in arteries. It reduces inflammation, improves lipid profiles, and inhibits platelet aggregation, commonly used to manage cardiovascular diseases, such as coronary artery disease, and prevent heart attacks and strokes. | DUKE | | Anti-autistic | 52217 | An agent that aims to alleviate symptoms of autism spectrum disorder (ASD), with potential therapeutic applications in managing social interaction, communication, and behavioral challenges. Key medical uses include reducing repetitive behaviors and improving cognitive function, although its effectiveness and biological role are still being researched. | DUKE | | Anti carpal-tunnel | | An agent that alleviates carpal-tunnel syndrome symptoms, such as inflammation and pain, by reducing pressure on the median nerve, commonly used in therapeutic applications including cortisone injections to relieve wrist discomfort. | DUKE | | Anti cheilitic | | An agent that treats cheilitis, reducing inflammation and discomfort. Examples include corticosteroids and anti-inflammatory agents, commonly used to manage cheilitis symptoms and promote healing. | DUKE | | Anti depressant | 52217 | An agent that regulates mood, reducing symptoms of depression and anxiety by altering neurotransmitter levels in the brain, commonly used in managing depression, anxiety disorders, and other mood disorders. | DUKE | | Anti dermatitic | 50177 | An agent that reduces skin inflammation and irritation, commonly used to treat dermatitis, eczema, and other skin disorders, providing relief from itching, redness, and swelling. | DUKE | | Anti-diabetic | 52217 | An agent that regulates blood sugar levels, enhancing insulin sensitivity or secretion. Therapeutically, it's used to manage diabetes, reducing symptoms and complications, and commonly prescribed to treat type 1 and 2 diabetes, as well as gestational diabetes. | DUKE | | Antidote | 50247 | An agent that counteracts a poison or toxin, neutralizing its harmful effects. It plays a biological role in reversing toxicity, and has therapeutic applications in treating poisoning, overdose, and envenomation. Key medical uses include emergency treatment for snake bites, drug overdose, and chemical exposure. | DUKE | | Anti dyskinetic | | An agent that relieves or prevents dyskinesia, improving voluntary movement. It plays a biological role in regulating motor function, and has therapeutic applications in managing Parkinson's disease, Huntington's disease, and other movement disorders, reducing involuntary movements and improving motor control. | DUKE | | Anti emetic | 50919 | An agent that prevents or alleviates nausea and vomiting, playing a crucial role in managing chemotherapy-induced, motion-induced, and post-operative nausea. Therapeutically, it helps reduce discomfort and prevent dehydration, commonly used in oncology, gastroenterology, and anesthesia. | DUKE | | Anti epileptic | 52217 | An agent that reduces seizure frequency and severity, commonly used in managing epilepsy, seizure disorders, and neuropathic pain. It stabilizes neuronal membranes, modulates neurotransmitter release, and inhibits abnormal electrical activity in the brain, providing therapeutic relief from convulsions and seizures. | DUKE | | Anti-glossitic | | An agent that relieves inflammation of the tongue, or glossitis, playing a role in reducing pain and discomfort. Therapeutically, it is used to treat tongue inflammation, often caused by nutritional deficiencies or infections. Key medical uses include managing glossitis symptoms, promoting oral health, and improving quality of life for patients with tongue inflammation. | DUKE | | Anti homocystinuric | | An agent that detects abnormal accumulation of homocysteine and its metabolites, used to diagnose homocystinuria, a condition associated with cardiovascular and neurological disorders. | DUKE | | Anti-hyperkinetic | | An agent that reduces excessive muscular activity, treating abnormal movements, such as tremors, tics, and chorea, with therapeutic applications in managing neurological disorders like Parkinson's disease, Huntington's disease, and dystonia. | DUKE | | Anti-hyperventilation | 52217 | An agent that reduces rapid breathing, helping to increase carbon dioxide levels in the blood. It plays a biological role in regulating breathing patterns, and has therapeutic applications in managing hyperventilation syndrome, anxiety disorders, and panic attacks, as well as key medical uses in emergency medicine and respiratory therapy. | DUKE | | Anti-infertility | 52217 | An agent that enhances reproductive health, promoting fertility and conception. Its biological role involves regulating hormonal balance and improving reproductive function. Therapeutically, it is used to treat infertility disorders, with key medical applications in assisted reproduction, polycystic ovary syndrome (PCOS), and unexplained infertility. | DUKE | | Anti-lithic | | An agent that prevents the formation of calculi (kidney stones) or promotes their dissolution, playing a key role in urology. Its therapeutic applications include managing kidney stone disease, nephrolithiasis, and urinary tract disorders, helping to alleviate pain and prevent complications. | DUKE | | Anti morning sickness | 52217 | An agent that alleviates nausea and vomiting, particularly during pregnancy. Its biological role is to regulate digestive system function and balance neurotransmitters. Therapeutically, it is used to manage hyperemesis gravidarum and morning sickness, improving quality of life for pregnant women. Key medical uses include preventing dehydration and nutrient deficiencies. | DUKE | | Anti monosodium-glutamate-sensitivity | | An agent that reduces adverse reactions to monosodium glutamate (MSG), a flavor enhancer. It alleviates symptoms such as headaches, nausea, and allergic reactions, commonly used in managing MSG sensitivity and related conditions, like Chinese Restaurant Syndrome. | DUKE | | Anti nephritic | 52217 | An agent that reduces kidney inflammation, commonly used to manage nephritis and other kidney disorders, helping to prevent kidney damage and promote renal health. | DUKE | | Anti neuritic | 52217 | An agent that protects nerve tissue, reducing inflammation and promoting nerve regeneration. It plays a biological role in maintaining nerve health and has therapeutic applications in treating conditions such as neuritis, neuralgia, and neuropathy, with key medical uses including pain management and nerve damage repair. | DUKE | | Anti neuropathic | | An agent that relieves symptoms such as pain, numbness, and tingling caused by damage or disease affecting the somatosensory nervous system, commonly used in managing conditions like diabetes, shingles, and nerve injuries. | DUKE | | Anti-oxaluric | | An agent that inhibits oxalate production or absorption, reducing urinary oxalate levels. It plays a biological role in preventing kidney stone formation. Therapeutically, it is used to manage hyperoxaluria, a condition characterized by excessive oxalate in the urine, and is a key medical treatment for preventing kidney stone recurrence. | DUKE | | Anti-Parkinsonian | 48407 | An agent that alleviates symptoms of Parkinson's disease, enhancing dopamine levels and improving motor function, commonly used to manage tremors, rigidity, and bradykinesia in neurodegenerative disorders. | DUKE | | Anti premenstrual syndrome | 52217 | An agent that alleviates symptoms of premenstrual syndrome (PMS), reducing physical and emotional discomfort. Its biological role involves regulating hormonal fluctuations, and its therapeutic applications include managing mood swings, bloating, and breast tenderness. Key medical uses include treating PMS, premenstrual dysphoric disorder (PMDD), and other menstrual-related disorders. | DUKE | | Anti prolactin | | An agent that inhibits prolactin production, a hormone regulating lactation and reproductive processes. Therapeutically, it's used to treat hyperprolactinemia, prolactinomas, and associated disorders, such as galactorrhea, infertility, and menstrual irregularities. | DUKE | | Anti-radiation | | An agent that repairs DNA damage caused by radiation exposure, playing a biological role in protecting cells. It has therapeutic applications in reducing radiation-induced side effects and key medical uses in cancer treatment, radiation poisoning, and space exploration. | DUKE | | Anti-schizophrenic | 52217 | An agent that reduces psychotic symptoms, commonly used in managing schizophrenia and other psychotic disorders, by modulating dopamine and serotonin levels in the brain, thereby alleviating hallucinations, delusions, and disorganized thinking. | DUKE | | Anti-seborrheic | 52217 | An agent that reduces seborrheic dermatitis symptoms, commonly used in managing scalp and skin conditions, such as dandruff, itching, and flaking, by inhibiting fungal growth and inflammation. | DUKE | | Anti-sickling | | An agent that prevents sickling of red blood cells, used to treat sickle cell anemia by reducing hemoglobin polymerization and improving blood flow, thereby alleviating associated pain and complications. | DUKE | | Anti-spasmodic | 52217 | An agent that relaxes smooth muscle, reducing muscle spasms and cramps. It plays a biological role in regulating muscle tone and is therapeutically applied to treat conditions such as irritable bowel syndrome, menstrual cramps, and muscle spasms, providing relief from abdominal pain and discomfort. | DUKE | | Anti TMJ | | An agent that relieves inflammation and pain in temporomandibular joint and muscle disorders, affecting the chewing muscles and joints connecting the lower jaw to the skull, used to treat TMJ syndrome, jaw pain, and lockjaw. | DUKE | | Anti ulcer | 49201 | An agent that reduces stomach acid and protects the mucous lining, preventing ulcer formation. It is used to treat conditions like gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome, promoting healing and relieving symptoms. | DUKE | | Anti vertigo | 52217 | An agent that alleviates vertigo symptoms, commonly used in managing balance disorders, inner ear conditions, and motion sickness, by regulating vestibular function and stabilizing inner ear balance. | DUKE | | Dopaminergic | 48560 | An agent that stimulates or regulates dopamine activity, playing a key role in movement, motivation, and reward processing. Therapeutically, dopaminergic agents are used to manage Parkinson's disease, restless leg syndrome, and certain psychiatric disorders, such as schizophrenia and depression. | DUKE | | Neurotoxic | 50910 | A substance that damages or destroys nerve cells, disrupting normal brain function. It has no therapeutic applications, but is used in research to study neurodegenerative diseases. Key medical uses include understanding and developing treatments for conditions like Alzheimer's and Parkinson's diseases, where neurotoxicity plays a role. | DUKE | | Progesteronigenic | | An agent that stimulates progesterone production, regulating menstrual cycles, pregnancy, and embryogenesis. Therapeutically, it's used to treat menstrual disorders, infertility, and pregnancy-related issues, such as preventing miscarriage and supporting embryonic development. | DUKE |
|
|---|
| Enzymes | | Name | Gene Name | UniProt ID |
|---|
| Phosphoserine aminotransferase | PSAT1 | Q9Y617 |
|
|---|
| Pathways | |
|---|
| Metabolism | Not Available |
|---|
| Biosynthesis | Not Available |
|---|
| Organoleptic Properties |
|---|
| Flavours | Not Available |
|---|
| Files |
|---|
| MSDS | Not Available |
|---|
| References |
|---|
| Synthesis Reference | Not Available |
|---|
| General Reference | Not Available |
|---|
| Content Reference | — Saxholt, E., et al. 'Danish food composition databank, revision 7.' Department of Nutrition, National Food Institute, Technical University of Denmark (2008). — U.S. Department of Agriculture, Agricultural Research Service. 2008. USDA National Nutrient Database for Standard Reference, Release 21. Nutrient Data Laboratory Home Page. — Duke, James. 'Dr. Duke's Phytochemical and Ethnobotanical Databases. United States Department of Agriculture.' Agricultural Research Service, Accessed April 27 (2004).
|
|---|